drugset / Trial / NCT01242254
A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD
Phase 1/2
Completed
36 enrolled
Chengdu Kanghong Biotech Co., Ltd.
Air Force Military Medical University, China · collabUniversity of Wisconsin, Madison · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to assess the efficacy and safety of multiple intravitreal injection of KH902 in patients with CNV due to AMD.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-03
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Conbercept | Protein / enzyme biologic | 0.5 mg | Intravitreal |
| Subject | Conbercept | Protein / enzyme biologic | 2 mg | Intravitreal |